Stay updated on Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedLocations section updated: Colorado, Massachusetts, New York, North Dakota, Ohio, South Dakota, and Texas are listed; corresponding state location entries were removed. Revision tag updated from v3.3.2 to v3.3.3.SummaryDifference0.6%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedThe Publications section wording was updated to state that publications are automatically filled in from PubMed and may not be about the study, replacing the previous phrasing. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check54 days agoChange DetectedThe government funding status notice banner was removed from the page. The study details and navigation remained unchanged.SummaryDifference0.3%

- Check69 days agoChange DetectedThe two screenshots show only layout and visual styling differences; no changes to core study information, eligibility criteria, endpoints, or enrollment details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check97 days agoChange DetectedAdded a government operating-status notice and updated version to v3.2.0; removed the previous v3.1.0 tag.SummaryDifference2%

- Check104 days agoChange DetectedThe page now shows a new version (v3.1.0) and expanded contact numbers, replacing the old v3.0.2; core content is updated mainly through versioning and contact details.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.